NAM
NTV Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Sell |
7,957
-1,215
| -13% | -$107K | 0.08% | 165 |
|
|
2025
Q1 | $836K | Buy |
9,172
+1,463
| +19% | +$133K | 0.11% | 134 |
|
|
2024
Q4 | $665K | Buy |
7,709
+271
| +4% | +$23.4K | 0.09% | 153 |
|
|
2024
Q3 | $707K | Buy |
7,438
+341
| +5% | +$32.4K | 0.09% | 149 |
|
|
2024
Q2 | $649K | Buy |
7,097
+2,102
| +42% | +$192K | 0.09% | 150 |
|
|
2024
Q1 | $453K | Buy |
+4,995
| New | +$453K | 0.07% | 174 |
|
|
2023
Q1 | – | Sell |
-2,600
| Closed | -$202K | – | 254 |
|
|
2022
Q4 | $202K | Buy |
+2,600
| New | +$202K | 0.04% | 240 |
|
|
2016
Q4 | – | Sell |
-4,850
| Closed | -$278K | – | 158 |
|
|
2016
Q3 | $278K | Sell |
4,850
-800
| -14% | -$45.9K | 0.1% | 145 |
|
|
2016
Q2 | $331K | Sell |
5,650
-300
| -5% | -$17.6K | 0.13% | 132 |
|
|
2016
Q1 | $342K | Hold |
5,950
| – | – | 0.13% | 134 |
|
|
2015
Q4 | $388K | Hold |
5,950
| – | – | 0.15% | 128 |
|
|
2015
Q3 | $374K | Hold |
5,950
| – | – | 0.12% | 154 |
|
|
2015
Q2 | $420K | Buy |
+5,950
| New | +$420K | 0.12% | 153 |
|